US CDRH criticism of EU regulatory system rebuffed by industry
This article was originally published in RAJ Devices
Implications by Jeffrey Shuren, director of the US Food and Drug Administration's Center for Devices and Radiological Health, that the EU system for regulating devices allows unsafe devices to reach the market and fails to live up to the US safety standards have been criticised by industry1.
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.